The NICE guidelines on obesity management do not include B12 supplementation as a therapeutic option for weight reduction in the absence of documented deficiency
Patients typically report initial reduction in pain or improvement in mobility within 1 to 2 weeks of starting BPC-157, with substantial healing changes between weeks 4 and 8
Vitamin B12 injections are generally safe, but some people may experience side effects, such as pain, redness, or swelling at the injection site, mild headaches, dizziness, nausea, or itching
No Therapeutic Use Exemption is available for BPC-157 because no regulatory authority has approved it for any indication
Medical contraindications and usewithcaution groups Even if regulators dont ban it outright, clinicians and safetyreview papers suggest avoiding or proceeding with extreme caution if you have: Active pancreatitis or high risk of pancreatitis Preclinical work links some GLP1like pathways (relevant to BPC157 formulations) with pancreatitis risk
It ensures that the first dose you measure is just as pure as the last